CVR: 25332520
Previous names: LICA PHARMACEUTICALS A/S
DKK 359,449
Gross profit
Net result: DKK 450,710
No owners listed
CVR · view ownership and management
Director role ended: Arsalan Kharazmi
CVR · 17/08/2026
View the full event history
LICA PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | 451 t. | 24.5 mio. | 24.2 mio. | 1 | |
| 202401/01/2024 – 31/12/2024 | - | 1.4 mio. | 24.2 mio. | 23.8 mio. | 1 | |
| 202301/01/2023 – 31/12/2023 | - | 1.7 mio. | 22.4 mio. | 22.4 mio. | 1 | |
| 202201/01/2022 – 31/12/2022 | - | -1.5 mio. | 20.7 mio. | 20.6 mio. | 1 | |
| 202101/01/2021 – 31/12/2021 | - | 2.6 mio. | 22.3 mio. | 22.2 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | - | 844 t. | 19.7 mio. | 19.6 mio. | 0 | |
| 201901/01/2019 – 31/12/2019 | - | 2.8 mio. | 18.9 mio. | 18.8 mio. | - | |
| 201801/01/2018 – 31/12/2018 | - | 5.6 mio. | 18.5 mio. | 18.4 mio. | - | |
| 201701/01/2017 – 31/12/2017 | - | 812 t. | 12.9 mio. | 12.8 mio. | - | |
| 201601/01/2016 – 31/12/2016 | - | 328 t. | 12.1 mio. | 12 mio. | - | |
| 201501/01/2015 – 31/12/2015 | - | -2.3 mio. | 11.7 mio. | 11.7 mio. | - | |
| 201401/01/2014 – 31/12/2014 | - | 3.9 mio. | 13.9 mio. | 13.9 mio. | - | |
| 201301/01/2013 – 31/12/2013 | - | 783 t. | 10.1 mio. | 10 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 468 t. | 953 t. | 9.3 mio. | 9.3 mio. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorLICA PHARMACEUTICALS ApS is registered in the Danish CVR register with the status unknown.
LICA PHARMACEUTICALS ApS was founded on 12 April 2000.
LICA PHARMACEUTICALS ApS was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
LICA PHARMACEUTICALS ApS had 1 employee in 2013 according to the Danish CVR register.
In 2025, LICA PHARMACEUTICALS ApS reported a gross profit of DKK 359,449.
LICA PHARMACEUTICALS ApS was located at c/o Arsalan Kharazmi, Tuborg Havnepark 2 1. tv, 2900 Hellerup.
As of August 17, 2026, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.
As of August 17, 2026, Arsalan Kharazmi has stepped down as adm. dir. of LICA PHARMACEUTICALS ApS.
Contact info changed: new phone: 40107500, new email: [email protected] (July 9, 2026).
Contact info changed: new phone: 40107500, new email: [email protected] (June 20, 2026).
Contact info changed: new phone: 40107500, new email: [email protected] (June 19, 2026).
Contact info changed: new phone: 40107500, new email: [email protected] (June 19, 2026).
Contact info changed: new phone: 40107500, new email: [email protected] (June 18, 2026).
As of June 18, 2026, Arsalan Kharazmi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of June 18, 2026, Karin Birgitte Sonne Kharazmi has stepped down as chairman of LICA PHARMACEUTICALS ApS.
As of June 18, 2026, Leila Eileen Gedsø-Kharazmi has stepped down as vice chairman of LICA PHARMACEUTICALS ApS.
On June 18, 2026, the company changed its name from LICA PHARMACEUTICALS A/S to LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2025. Gross profit came to DKK 359,449, and the net result was DKK 450,710.
LICA PHARMACEUTICALS ApS has published its annual report for 2024. Gross profit came to DKK 210,297, and the net result was DKK 1,406,816.
LICA PHARMACEUTICALS ApS has published its annual report for 2023. Gross profit came to DKK 234,223, and the net result was DKK 1,731,068.
LICA PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK 312,597, and the net result was DKK -1,524,785.
LICA PHARMACEUTICALS ApS has published its annual report for 2021. Gross profit came to DKK 370,721, and the net result was DKK 2,563,807.
LICA PHARMACEUTICALS ApS has published its annual report for 2020. Gross profit came to DKK 326,213, and the net result was DKK 843,617.
As of December 31, 2020, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of December 31, 2020, Grant Thornton, Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2019. Gross profit came to DKK 279,654, and the net result was DKK 2,782,288.
LICA PHARMACEUTICALS ApS has published its annual report for 2018. Gross profit came to DKK 973,018, and the net result was DKK 5,572,310.
LICA PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK 408,690, and the net result was DKK 812,469.
LICA PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK 737,979, and the net result was DKK 327,524.
LICA PHARMACEUTICALS ApS has published its annual report for 2015. Gross profit came to DKK 312,007, and the net result was DKK -2,255,485.
As of December 21, 2015, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of December 21, 2015, EY Godkendt Revisionspartnerselskab has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2014. Gross profit came to DKK 269,406, and the net result was DKK 3,869,932.
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK 341,415, and the net result was DKK 782,891.
LICA PHARMACEUTICALS ApS has published its annual report for 2012. Revenue came to DKK 468,291, and the net result was DKK 953,184.
As of September 18, 2012, JUT NR. 2180 A/S has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of May 25, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LICA PHARMACEUTICALS ApS.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of July 1, 2011, A/S PSE NR. 2857 has stepped down as auditor of LICA PHARMACEUTICALS ApS.
As of January 11, 2008, Mark Sonne Kharazmi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Mark Sonne Kharazmi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Søren Brøgger Christensen has left the board of directors of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Karin Birgitte Sonne Kharazmi is registered as chairman of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Leila Eileen Gedsø-Kharazmi is registered as vice chairman of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Michael Betto Vibe Fiorini has stepped down as chairman of LICA PHARMACEUTICALS ApS.
As of February 4, 2005, Eva Steiness has stepped down as vice chairman of LICA PHARMACEUTICALS ApS.
As of May 6, 2004, Michele Garufi has left the board of directors of LICA PHARMACEUTICALS ApS.
As of September 30, 2003, Søren Brøgger Christensen has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of September 30, 2003, Per Anders Göte Samuelsson has left the board of directors of LICA PHARMACEUTICALS ApS.
As of September 30, 2003, Gunnar Magnus Severus Modée Persson has left the board of directors of LICA PHARMACEUTICALS ApS.
As of April 3, 2001, Michele Garufi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 22, 2000, Gunnar Magnus Severus Modée Persson has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 22, 2000, Björn Ingemar Odlander has left the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Björn Ingemar Odlander has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Per Anders Göte Samuelsson has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Eva Steiness is registered as vice chairman of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Arsalan Kharazmi is registered as adm. dir. of LICA PHARMACEUTICALS ApS.
As of November 10, 2000, Per Thor Lassen has stepped down as adm. dir. of LICA PHARMACEUTICALS ApS.
As of June 1, 2000, Per Thor Lassen has left the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, A/S PSE NR. 2857 has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Per Thor Lassen has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Arsalan Kharazmi has joined the board of directors of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Per Thor Lassen is registered as adm. dir. of LICA PHARMACEUTICALS ApS.
As of April 12, 2000, Michael Betto Vibe Fiorini is registered as chairman of LICA PHARMACEUTICALS ApS.
LICA PHARMACEUTICALS ApS was founded on April 12, 2000.
Companies in the same industry and area
CVR 26392861
CVR 41366044
CVR 32971024
CVR 27701396
CVR 43932489
